Prostate cancer and health‐related quality of life: a review of the literature

Eton, David T.; Lepore, Stephen J.

doi:10.1002/pon.572

Cited by 287 publications

(277 citation statements)

References 59 publications

(123 reference statements)

Supporting

Mentioning

259

Contrasting

Unclassified

Order By: Relevance

“…Most men treated for PCa survive many years and suffer from treatment-related complications. 43 Managing the disease and its treatments long-term is even more crucial for ethnic minorities as they are less likely to discuss treatment-related complications with their physicians, 44 potentially leading to poorer QOL outcomes following treatment for PCa. [33][34][35] In addition, ethnic minority men, who are more likely to be in lower socioeconomic categories, typically have worse QOL outcomes and longer recovery periods from PCa treatments.…”

Section: Discussionmentioning

confidence: 99%

Interventions to Improve Decision Making and Reduce Racial and Ethnic Disparities in the Management of Prostate Cancer: A Systematic Review

2012

View full text Add to dashboard Cite

OBJECTIVES: Ethnic minorities are disproportionately impacted by prostate cancer (PCa) and are at risk for not receiving informed decision making (IDM). We conducted a systematic literature review on interventions to improve: (1) IDM about PCa in screeningeligible minority men, and (2) quality of life (QOL) in minority PCa survivors. DATA SOURCES: MeSH headings for PCa, ethnic minorities, and interventions were searched in MED-LINE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, CINAHL, and PsycINFO. SUBJECT ELIGIBILITY CRITERIA: We identified U.S.-based, English-language articles (1985-2010) on interventions to improve PCa IDM and QOL that included 50 % or more minority patients or analyses stratified by race/ethnicity. STUDY APPRAISAL AND SYNTHESIS METHODS:Articles (n=19) were evaluated and scored for quality using a Downs and Black (DB) system. Interventions were organized by those enhancing 1) IDM about PCa screening and 2) improving QOL and symptom among PCa survivors. Outcomes were reported by intervention type (educational seminar, printed material, telephonebased, video and web-based). RESULTS: Fourteen studies evaluated interventions for enhancing IDM about PCa screening and five evaluated programs to improve outcomes for PCa survivors. Knowledge scores were statistically significantly increased in 12 of 13 screening studies that measured knowledge, with ranges of effect varying across intervention types: educational programs (13 %-48 % increase), print (11 %-18 %), videotape/DVD (16 %), and web-based (7 %-20 %). In the final screening study, an intervention to improve decision-making about screening increased decisional self-efficacy by 9 %. Five cognitive-behavioral interventions improved QOL among minority men being treated for localized PCa through enhancing problem solving and coping skills. LIMITATIONS: Weak study designs, small sample sizes, selection biases, and variation in follow-up intervals across studies. CONCLUSIONS: Educational programs were the most effective intervention for improving knowledge among screening-eligible minority men. Cognitive behavioral strategies improved QOL for minority men treated for localized PCa.

show abstract

Section: Discussionmentioning

confidence: 99%

Interventions to Improve Decision Making and Reduce Racial and Ethnic Disparities in the Management of Prostate Cancer: A Systematic Review

2012

View full text Add to dashboard Cite

show abstract

“…67 For early-stage cancer, primary treatment options are radical prostatectomy, radiation therapy and active surveillance, which can lead to differences in specific areas of functioning, such as sexual, urinary or bowel functioning over time. 68 Because surgery and radiation treatments seem to be equally effective in treating early-stage prostate cancer, controversy exists about selection of primary treatments for prostate cancer. 69 Early treatment decisions are fraught with the sense of having to choose between QOL and longevity, even though it is unclear what the outcome will be on either side of the balance.…”

Section: Psychological Issues In Prostate Cancer Related To Developmementioning

confidence: 99%

Psychological aspects of prostate cancer: a clinical review

Sousa

Sonavane

Mehta

2012

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

Prostate cancer is the most common non-skin cancer in men. It is fraught with both physical and psychological symptomatology. Depression, anxiety, stress, fatigue, pain and psychosocial factors all affect the patient with prostate cancer. Impotence, erectile dysfunction, sexual issues and incontinence in these patients complicate matters further. Anxiety may exist both before testing and while awaiting test results. Confusion over choosing from various interventions often adds to anxiety and depression in these patients. Various demographic factors and the developmental stage of the couple affect these psychological symptoms. The caregiver may undergo significant psychological turmoil while caring for a patient diagnosed with prostate cancer, which is addressed. The role of nurses in the management of prostate cancer is discussed. The present review looks at psychological issues in patients with prostate cancer from a clinical perspective, with the aim of highlighting these issues for the clinical urologist dealing with these patients. It also explores the consultation --liaison relationship between psychiatrists, psychologists and urologists as a team for the multimodal management of prostate cancer.

show abstract

“…4 However, there is a paucity of high quality evidence comparing these treatments to guide patients and clinicians in their treatment choices 5 and adverse effects including impotence are common, persistent and associated with reduced quality of life. 6,7 Men with prostate cancer may choose to supplement their conventional treatment with one or more forms of complementary or alternative medicine (CAM).…”

Section: Introductionmentioning

confidence: 99%

Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies

Bishop

Rea

Lewith

et al. 2010

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

Men with prostate cancer are reported as commonly using complementary and alternative medicine (CAM) but surveys have not recently been subjected to a rigorous systematic review incorporating quality assessment. Six electronic databases were searched using pre-defined terms. Detailed information was extracted systematically from each relevant article. Study reporting quality was assessed using a quality assessment tool, which demonstrated acceptable inter-rater reliability and produces a percentage score. In all, 42 studies are reviewed. All were published in English between 1999 and 2009; 60% were conducted in the United States. The reporting quality was mixed (median score ¼ 66%, range 23-94%). Significant heterogeneity precluded formal meta-analysis. In all, 39 studies covering 11 736 men reported overall prevalence of CAM use; this ranged from 8 to 90% (median ¼ 30%). In all, 10 studies reported prevalence of CAM use specifically for cancer care; this ranged from 8 to 50% (median ¼ 30%). Some evidence suggested CAM use is more common in men with higher education/incomes and more severe disease. The prevalence of CAM use among men with prostate cancer varies greatly across studies. Future studies should use standardised and validated data collection techniques to reduce bias and enhance comparability.

show abstract

Prostate cancer and health‐related quality of life: a review of the literature

Cited by 287 publications

References 59 publications

Interventions to Improve Decision Making and Reduce Racial and Ethnic Disparities in the Management of Prostate Cancer: A Systematic Review

Interventions to Improve Decision Making and Reduce Racial and Ethnic Disparities in the Management of Prostate Cancer: A Systematic Review

Psychological aspects of prostate cancer: a clinical review

Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies

Contact Info

Product

Resources

About